abstract |
The present invention relates to pharmaceutical compositions comprising the drug substance ( R,E )- N -(7-chloro-1-(1-(4-(dimethylamino)but-2-enoyl)azepan-3-yl)-1 H -benzo[d]imidazol-2- yl)-2-methylisonicotinamide, and processes to prepare said pharmaceutical compositions. |